Sun Pharmaceutical Shows Mixed Performance Amid Sector Outperformance and Trend Reversal
Sun Pharmaceutical Industries has shown significant trading activity, maintaining a stable price after recent gains. The stock is above several short-term moving averages but below the long-term 200-day average. With a market cap of Rs 4,16,273.00 crore, the company has experienced mixed performance metrics over various time frames.
Sun Pharmaceutical Industries has shown notable activity today, with the stock outperforming its sector by 0.36%. However, it has experienced a trend reversal, falling after two consecutive days of gains. The stock opened at Rs 1711.2 and has maintained this price throughout the trading session. In terms of moving averages, Sun Pharmaceutical's stock is currently above the 5-day, 20-day, 50-day, and 100-day moving averages, yet it remains below the 200-day moving average, indicating mixed short-term and long-term performance trends.
The company operates within the Pharmaceuticals & Biotechnology industry and boasts a market capitalization of Rs 4,16,273.00 crore. Its price-to-earnings (P/E) ratio stands at 36.40, slightly below the industry average of 37.11.
Looking at recent performance metrics, Sun Pharmaceutical's one-year performance is down by 0.09%, while the Sensex has declined by 1.05%. Over the past month, the stock has gained 2.94%, contrasting with a 3.36% drop in the Sensex. Despite a challenging year-to-date performance of -8.93%, the company has shown resilience over longer periods, with a three-year growth of 81.89% compared to the Sensex's 40.50%.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Sun Pharmaceutical Industries Sees Notable Surge in Derivatives Open Interest Amid Market Volatility
Most Read
